Latest News & Features
Asia-Pacific
UK-based Crescendo Biologics has agreed a global licensing deal with biopharma company Zai Lab which will see Zai Lab develop and commercialise an antibody, “VH domain therapeutic”, for applications in inflammatory diseases. 31 May 2018
Americas
The US government has required German company Bayer to divest $9 billion worth of business and assets in order to continue with its proposed $66 billion acquisition of US-based Monsanto. 30 May 2018
Americas
Research and development, strong IP rights and good international relations are all factors in Brazil’s rise as a soybean-producing powerhouse, as Gabriel Di Blasi and Matheus Gil do Amaral of Di Blasi Parente & Associados report. 29 May 2018
Americas
Molecular diagnostics company Myriad Genetics has agreed to acquire Counsyl, a genetic screening company, for $375 million. 29 May 2018
Americas
Pfizer has sued Canadian pharmaceutical company Apotex over its plan to make and sell a generic version of Pfizer’s Inlyta tablets. 29 May 2018
Big Pharma
The European Commission has proposed a change in IP rules to allow pharmaceutical companies to produce generic drugs for export to non-EU countries that don’t have patent protection. 29 May 2018
Americas
A judge has found it unlikely that Impax Laboratories would launch a generic drug before a final court decision in related patent litigation and has dismissed a case against the company. 25 May 2018
Americas
Pharmaceutical company UCB has emerged victorious in a case against major generic drug companies after its patent win was affirmed on appeal. 24 May 2018
Americas
Animal health company Boehringer Ingelheim Vetmedica has sued Merck & Co and Merck Animal Health for infringing three patents covering vaccines for treating pig disease. 23 May 2018
Americas
Corteva Agriscience, the agriculture division of DowDuPont, has signed a licensing deal with Monsanto to use its technology for fighting insects found on corn. 23 May 2018